ArticleOncotarget2024

Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia.

Simonetta I Gaumond et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.